8.30p+0.05 (+0.61%)11 Jul 2025, 11:00
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo

Allergy Therapeutics PLC Market & Company News

07:00AGYPDMR DealingsRNS
13.06.2025 07:00AGYAllergy Therapeutics presents findings at EAACIReach
10.06.2025 07:04AGYEAACI Early Career Research AwardReach
31.03.2025 12:24AGYAllergy Therapeutics half-year loss narrows on lower expensesAlliance
31.03.2025 07:00AGYInterim Results for six months ended 31 Dec 2024RNS
27.03.2025 18:27AGYAllergy Therapeutics peanut allergy vaccine trial enters final phaseAlliance
27.03.2025 07:00AGYAdvancement to final phase of PROTECT trialRNS
03.03.2025 07:00AGYNew Executive Long Term Incentive AwardsRNS
27.02.2025 07:00AGYPresentations at 2025 AAAAI / WAO Joint CongressReach
17.02.2025 07:00AGYGrass MATA MPL Phase III data published in AllergyRNS
14.02.2025 07:00AGYGrant of OptionsRNS
28.01.2025 21:19AGYIN BRIEF: Allergy Therapeutics expects annual sales to rise on-yearAlliance
28.01.2025 07:00AGYHalf Year Trading updateRNS
22.01.2025 07:00AGYPDMR Dealing and Total Voting RightsRNS
15.01.2025 07:00AGYDirector/PDMR ShareholdingRNS
19.12.2024 13:41AGYExercise of Options and Total Voting RightsRNS
17.12.2024 16:19AGYBlock Listing Interim ReviewRNS
09.12.2024 11:30TSTL, TRAC, SUPRUK shareholder meetings calendar - next 7 daysAlliance
04.12.2024 07:00AGYPositive Interim Data from PROTECT TrialRNS
27.11.2024 16:52AGYIN BRIEF: Allergy Therapeutics treats first patient in allergy trialAlliance
27.11.2024 07:00AGYFirst Patient Dosed in G308 Paediatric TrialRNS
25.11.2024 07:00AGYSubmission of MAA for Grass MATA MPLRNS
21.11.2024 07:00AGYNotice of 2024 Annual General MeetingRNS
06.11.2024 11:22AGYAllergy Therapeutics annual loss narrows thanks to reduced expensesAlliance
06.11.2024 07:00AGYAudited Preliminary Results 2024RNS
21.10.2024 07:00AGYCommencement of Phase III Paediatric TrialRNS
16.10.2024 10:58AGYAllergy Therapeutics shares surge as enters into secured loan facilityAlliance
16.10.2024 07:00AGYUpdate on fundingRNS
01.10.2024 07:00AGYUpdate on funding and preliminary resultsRNS
17.09.2024 07:00AGYProgression of patient cohorts in PROTECT TrialRNS
27.08.2024 10:46AGY, GROC, BELLAIM WINNERS & LOSERS: Belluscura shares up on expected revenue boostAlliance
27.08.2024 09:57AGYAllergy Therapeutics secures cash to see it through SeptemberAlliance
27.08.2024 07:00AGYUpdate on fundingRNS
Showing 1 to 33 of 33